This company has been marked as potentially delisted and may not be actively trading. NYSE:TCO Taubman Centers (TCO) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Taubman Centers Stock (NYSE:TCO) 30 days 90 days 365 days Advanced Chart Get Taubman Centers alerts:Sign Up Key Stats Today's Range$42.99▼$42.9950-Day Range$42.91▼$43.0052-Week Range$26.24▼$53.40VolumeN/AAverage Volume1.96 million shsMarket Capitalization$2.65 billionP/E Ratio15.86Dividend Yield6.28%Price TargetN/AConsensus RatingN/A Company Overview Taubman Centers is an S&P MidCap 400 Real Estate Investment Trust engaged in the ownership, management and/or leasing of 26 regional, super-regional and outlet malls in the U.S. and Asia. Taubman's U.S.-owned properties are the most productive in the publicly held U.S. mall industry. Founded in 1950, Taubman is headquartered in Bloomfield Hills, Mich. Taubman Asia, founded in 2005, is headquartered in Hong Kong. Read More Receive TCO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Taubman Centers and its competitors with MarketBeat's FREE daily newsletter. Email Address TCO Stock News HeadlinesTaubman Centers Stock Price Today | NYSE: TCO Live - Investing.comJune 28, 2025 | investing.comContractors announce start of construction on new cancer centerMay 1, 2025 | msn.comThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.July 12 at 2:00 AM | Brownstone Research (Ad)Taubman Centers Inc Pj Pref (TCO_pj)December 5, 2024 | uk.investing.comCarilion breaks ground on $100M Carilion Taubman Cancer Center in RoanokeNovember 1, 2024 | yahoo.comCarilion Clinic breaks ground on Taubman Cancer CenterNovember 1, 2024 | msn.comCarilion Clinic prepares to break ground on Taubman Cancer CenterOctober 30, 2024 | msn.comNew Taubman exhibition to feature Art Nouveau trailblazer Alphonse MuchaOctober 16, 2024 | msn.comSee More Headlines TCO Stock Analysis - Frequently Asked Questions How were Taubman Centers' earnings last quarter? Taubman Centers, Inc. (NYSE:TCO) announced its quarterly earnings results on Monday, November, 9th. The real estate investment trust reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.58 by $1.07. The company's quarterly revenue was down 19.4% compared to the same quarter last year. What other stocks do shareholders of Taubman Centers own? Based on aggregate information from My MarketBeat watchlists, some other companies that Taubman Centers investors own include Simon Property Group (SPG), Chevron (CVX), Intel (INTC), Cisco Systems (CSCO), Bristol Myers Squibb (BMY), Occidental Petroleum (OXY) and Walt Disney (DIS). Company Calendar Last Earnings11/09/2020Today7/12/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorFinance Industry Real Estate Investment Trusts Sub-IndustryRetail REITs Current SymbolNYSE:TCO CIK890319 Webwww.taubman.com Phone248-258-6800FaxN/AEmployees420Year FoundedN/AProfitability EPS (Trailing Twelve Months)$3.71 Trailing P/E Ratio15.86 Forward P/E Ratio16.04 P/E GrowthN/ANet Income$229.48 million Net Margins30.09% Pretax MarginN/A Return on Equity-94.88% Return on Assets4.04% Debt Debt-to-Equity RatioN/A Current Ratio1.62 Quick Ratio1.62 Sales & Book Value Annual Sales$661.05 million Price / Sales4.01 Cash Flow$8.13 per share Price / Cash Flow5.29 Book Value($2.90) per share Price / Book-14.82Miscellaneous Outstanding Shares61,725,000Free FloatN/AMarket Cap$2.65 billion OptionableOptionable Beta-0.07 Elon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free Report This page (NYSE:TCO) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Taubman Centers, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Taubman Centers With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
